Drug Shortage Report for NORMOSOL-R
| Report ID | 83899 |
| Drug Identification Number | 00039500 |
| Brand name | NORMOSOL-R |
| Common or Proper name | NormosolTM-R pH approx. 7.4 (Multiple Electrolytes Injection Type 1 USP) |
| Company Name | ICU MEDICAL CANADA INC |
| Market Status | DORMANT |
| Active Ingredient(s) | SODIUM ACETATE MAGNESIUM CHLORIDE POTASSIUM CHLORIDE SODIUM CHLORIDE SODIUM GLUCONATE |
| Strength(s) | 2.22MG 0.14MG 0.37MG 5.26MG 5.02MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1000 ml |
| ATC code | B05BB |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2019-07-01 |
| Actual start date | |
| Estimated end date | 2019-07-03 |
| Actual end date | 2019-06-20 |
| Shortage status | Avoided shortage |
| Updated date | 2019-06-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2019-06-20 | French | Compare |
| v3 | 2019-06-20 | English | Compare |
| v2 | 2019-05-13 | French | Compare |
| v1 | 2019-05-13 | English | Compare |
Showing 1 to 4 of 4